The Effect of Paclitaxel on Patients with Peripheral Arterial Disease: A Review of Current Literature and Best Practices

The Effect of Paclitaxel on Patients with Peripheral Arterial Disease: A Review of Current Literature and Best Practices

On-Demand Webcast
FACULTY

Jihad A. Mustapha, MD
Advanced Cardiac & Vascular Amputation Prevention Centers
Michigan State University College of Osteopathic Medicine
Grand Rapids, Michigan 

Michael R. Jaff, DO
Newton-Wellesley Hospital
Harvard Medical School 
Boston, Massachussetts 

Gary M. Ansel, MD
OhioHealth (Riverside/Methodist Hospital)
Medical University of Ohio
Toledo, Ohio

George L. Adams, MD
UNC REX Healthcare
University of North Carolina Chapel Hill Medical Center
Chapel Hill, North Carolina

INTENDED LEARNERS

This activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, cardiothoracic surgeons, podiatrists, nurses, technicians  and others involved in the treatment of peripheral arterial disease. 

Learning Objectives

After participating in this activity, participants should be better able to:

  • Review the recent findings and literature, mechanisms of action, benefit and risks of paclitaxel
  • Discuss the safety considerations in PAD applications
  • Evaluate the facts and make necessary adjustments to practice
CLAIMING CREDIT

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: February 1, 2019
Expiration Date: February 1, 2020
Estimated time to complete: 1 hour

CONTINUING EDUCATION

  In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this on-demand activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UEMS/EACCME CME Credit Recognition

The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.

NURSING

This continuing nursing education activity awards up to 1.0 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hours.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewer
Adam Geronemus, MD
Miami Cardiac & Vascular Institute
Miami, Florida

 

Faculty
The faculty has reported the following:

Dr. Michael R. Jaff: Consultant – American Orthotics and Prosthetics Association, Micell, Philips, Silk Road Medical, Vactronix, Venarum, Volcano; Major Stock Shareholder – Embolitech, Gemini, Janacare, MC10, PQ Bypass, Primacea, Sano V, Vascular Therapies

Dr. Jihad A. Mustapha: Consultant - BD Bard, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Micromedical Solutions, Philips, PQ Bypass, Reflow Medical, Terumo; Major Stock Shareholder – Cardio Flow

Dr. Gary Ansel: Consultant - Abbott Vascular, Boston Scientific, CR Bard, SurModics, W.L. Gore; Speakers Bureau – Medtronic

Dr. Adam Geronemus: Speakers’ Bureau - Bard, Gore, Merit, Penumbra, Sirtex

Dr. George Adams: Consultant – Abbott Vascular, Asahi Intecc, BD Bard, Boston Scientific, Cardiovascular Systems, Cook Medical,Gore, Medtronic, Philips, Shockwave Medical, Soundbite, Terumo Medical, W.L. Gore

 

Planning Committee

In addition to the above, Donna Brophy, MaryEllen Fama, Caitlin Eastman, Todd Kunkler, Randy Robbin, and Susan Yarbrough (NACCME) disclosed no relevant financial relationships with any commercial interests.

EDUCATIONAL GRANT SUPPORT

This activity is supported by educational grants from Boston Scientific, BD Peripheral Intervention, Cook Medical, Medtronic, and Philips IGTD.

ADA STATEMENT

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

PROVIDER STATEMENT

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.